Planoptik (P4O) H2 2025 earnings summary

Executive summary

• Consolidation of core operations under one entity and brand, with divestment of non-core activities and a focus on microelectronics and microfluidics markets.

• Uplisting to the General Standard of the regulated market to enhance transparency and access to new investor groups.

• Despite challenging macroeconomic conditions and customer inventory reductions, preparations for future growth and new customer ramp-ups were made.

Financial highlights

• Group revenue decreased to €11.27m in 2025 from €11.86m in 2024 (IFRS), below the original plan of €12–13m.

• EBITDA fell to €1.60m (2024: €2.51m), EBIT to €0.13m (2024: €1.11m), and EBT to -€0.02m (2024: €1.03m).

• Net result was -€0.06m (2024: €0.68m), with EPS at -€0.01 (2024: €0.15).

• Cash flow from operations dropped to €0.27m (2024: €2.36m); total cash flow was -€1.48m (2024: €0.49m).

• Equity ratio improved to 68.5% (2024: 65.3%), with equity at €12.69m (2024: €12.75m).

Outlook and guidance

• Revenue expected to rise by over €1m in 2026, driven by demand recovery from key customers and initial ramp-up of new component business.

• Significant growth acceleration anticipated from 2027 as new customer series production scales up.

• EBT in 2026 projected to increase but remain below €0.5m due to ongoing cost pressures.

• No dividend planned; liquidity expected to remain stable despite high investment levels.